NewGenIvf Statistics Share Statistics NewGenIvf has 1.83M
shares outstanding. The number of shares has increased by 0.02%
in one year.
Shares Outstanding 1.83M Shares Change (YoY) 0.02% Shares Change (QoQ) 0.05% Owned by Institutions (%) n/a Shares Floating 1.65M Failed to Deliver (FTD) Shares 48,099 FTD / Avg. Volume 5.31%
Short Selling Information The latest short interest is 92.77K, so 1.32% of the outstanding
shares have been sold short.
Short Interest 92.77K Short % of Shares Out 1.32% Short % of Float 1.32% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -439.14 and the forward
PE ratio is null.
NewGenIvf's PEG ratio is
1.57.
PE Ratio -439.14 Forward PE n/a PS Ratio 42.43 Forward PS n/a PB Ratio -219.86 P/FCF Ratio -27.72 PEG Ratio 1.57
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for NewGenIvf.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.17,
with a Debt / Equity ratio of -2.89.
Current Ratio 1.17 Quick Ratio 1.14 Debt / Equity -2.89 Debt / EBITDA 125.67 Debt / FCF -0.36 Interest Coverage -1.49
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $71.49K Profits Per Employee $-6.91K Employee Count 76 Asset Turnover 1.52 Inventory Turnover 44.62
Taxes Income Tax -487K Effective Tax Rate 50.68%
Stock Price Statistics The stock price has increased by -99.78% in the
last 52 weeks. The beta is -0.1, so NewGenIvf's
price volatility has been lower than the market average.
Beta -0.1 52-Week Price Change -99.78% 50-Day Moving Average 5.42 200-Day Moving Average 195.23 Relative Strength Index (RSI) 27.41 Average Volume (20 Days) 905,791
Income Statement In the last 12 months, NewGenIvf had revenue of 5.43M
and earned -525K
in profits. Earnings per share was -23.05.
Revenue 5.43M Gross Profit 1.83M Operating Income -1.16M Net Income -525K EBITDA 24.11K EBIT -182K Earnings Per Share (EPS) -23.05
Full Income Statement Balance Sheet The company has 457.74K in cash and 3.03M in
debt, giving a net cash position of -2.57M.
Cash & Cash Equivalents 457.74K Total Debt 3.03M Net Cash -2.57M Retained Earnings -985.99K Total Assets 3.78M Working Capital 452.39K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -8.26M
and capital expenditures -53.04K, giving a free cash flow of -8.32M.
Operating Cash Flow -8.26M Capital Expenditures -53.04K Free Cash Flow -8.32M FCF Per Share -14.61
Full Cash Flow Statement Margins Gross margin is 33.63%, with operating and profit margins of -21.35% and -9.66%.
Gross Margin 33.63% Operating Margin -21.35% Pretax Margin -17.69% Profit Margin -9.66% EBITDA Margin 0.44% EBIT Margin -21.35% FCF Margin -153.09%
Dividends & Yields NIVF does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for NIVF.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Aug 4, 2025. It was a
backward
split with a ratio of 1:5.
Last Split Date Aug 4, 2025 Split Type backward Split Ratio 1:5
Scores Altman Z-Score 1.76 Piotroski F-Score 2
